- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 58.39M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 76.74M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 10.04K sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $3.52M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$4.83M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$3.54M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $4.4M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $7.28M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $197.9M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $300.91M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.28M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.06M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.81M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.02M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $27.84M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $31.16M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $200.71M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $303.93M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.30 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$382.29 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.30 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$382.29 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$99.8M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.84M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$99.62M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$4.01M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $3.44M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | −$72K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $180K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $121K |